메뉴 건너뛰기
Journal of Allergy and Clinical Immunology
Volumn 114, Issue 3, 2004, Pages 695-697
Effect of topical pimecrolimus on epicutaneous skin testing [5]
Author keywords

[No Author keywords available]
Indexed keywords

ALLERGEN; CODEINE; HISTAMINE; PIMECROLIMUS; PLACEBO; SODIUM CHLORIDE;
EID: 4444379716     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.05.067     Document Type: Letter
Times cited : (10)
References (5)
  • 1
    • 0022181087 scopus 로고
    • Food hypersensitivity and atopic dermatitis: Evaluation of 113 patients
    • Sampson H.A., McCaskill C.C. Food hypersensitivity and atopic dermatitis: evaluation of 113 patients. J Pediatr. 107:1985;669-675
    • (1985) J Pediatr , vol.107 , pp. 669-675
    • Sampson, H.A.1    McCaskill, C.C.2
  • 2
    • 0036553479 scopus 로고    scopus 로고
    • Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents
    • Eichenfield L., Lucky A., Boguniewicz M., Langley R., Cherill R., Marshall K., et al. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol. 46:2002;495-504
    • (2002) J Am Acad Dermatol , vol.46 , pp. 495-504
    • Eichenfield, L.1    Lucky, A.2    Boguniewicz, M.3    Langley, R.4    Cherill, R.5    Marshall, K.6
  • 3
    • 0036677154 scopus 로고    scopus 로고
    • Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug
    • Kapp A., Papp K., Bingham A., Folster-Holst R., Ortonne J.P., Potter P.C., et al. Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allergy Clin Immunol. 110:2002;277-284
    • (2002) J Allergy Clin Immunol , vol.110 , pp. 277-284
    • Kapp, A.1    Papp, K.2    Bingham, A.3    Folster-Holst, R.4    Ortonne, J.P.5    Potter, P.C.6
  • 4
    • 0034909508 scopus 로고    scopus 로고
    • The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils
    • Zuberbier T., Chong S.U., Grunow K., Guhl S., Welker P., Grassberger M., et al. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. J Allergy Clin Immunol. 108:2001;275-280
    • (2001) J Allergy Clin Immunol , vol.108 , pp. 275-280
    • Zuberbier, T.1    Chong, S.U.2    Grunow, K.3    Guhl, S.4    Welker, P.5    Grassberger, M.6
  • 5
    • 4444313456 scopus 로고    scopus 로고
    • The effect of pimecrolimus on prick skin testing
    • [abstract]
    • Chang E.E., El-Dahr J.M. The effect of pimecrolimus on prick skin testing. [abstract] J Allergy Clin Immunol. 111:2003;s350
    • (2003) J Allergy Clin Immunol , vol.111 , pp. 350
    • Chang, E.E.1    El-Dahr, J.M.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.